All-trans arachidonic acid generates reactive oxygen species via xanthine dehydrogenase/xanthine oxidase interconversion in the rat liver cytosol in vitro

Journal of Clinical Biochemistry and Nutrition

Volumn 51, Issue 1, 2012, Pages 55-60

  Sakuma, Satoru ^a   Kitamura, Takahiro ^a   Kuroda, Chihiro ^a   Takeda, Kanami ^a   Nakano, Sayaka ^a   Hamashima, Tomohiro ^a   Kohda, Tetsuya ^a   Wada, Shun Ichi ^a   Arakawa, Yukio ^a   Fujimoto, Yohko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

All cis arachidonic acid; All trans arachidonic acid; Reactive oxygen species; Xanthine dehydrogenase; Xanthine oxidase

Indexed keywords

ALL TRANS ARACHIDONIC ACID; ALLOPURINOL; ARACHIDONIC ACID DERIVATIVE; COPPER ION; DICHLOROFLUORESCEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; LIVER CYTOSOL; NONHUMAN; RAT;

RATTUS;

EID: 84863422060     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-97     Document Type: Article

References (35)

1. Ghoneim AI, Abdel-Naim AB, Khalifa AE, El-Denshary ES. Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain. Pharmacol Res 2002; 46: 273-279. (Pubitemid 35300767)
2. Fernández L, Carrasco-Chaumel E, Serafin A, et al. Is ischemic preconditioning a useful strategy in steatotic liver transplantation? Am J Transplant 2004; 4: 888-899. (Pubitemid 38745587)
3. Curek GD, Cort A, Yucel G, et al. Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion. Toxicology 2010; 267: 147-153.
4. Della CE, Stirpe F. The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. Biochem J 1972; 126: 739-745.
5. Kamiński ZW, Jezewska MM. Intermediate dehydrogenase-oxidase form of xanthine oxidoreductase in rat liver. Biochem J 1979; 181: 177-182. (Pubitemid 9236528)
6. 2+ and selenium ions. J Pharm Pharmacol 1994; 46: 487-490.
7. 2+-induced conversion of xanthine dehydrogenase to oxidase in rabbit liver. Free Radic Biol Med 1995; 19: 487-491.
8. Rudrum M. Trans fatty acids: consensus and debate. Eur J Med Res 1995; 1: 115-117.
9. Feldman EB, Kris-Etherton PM, D. Kritchevsky D, Lichtenstein AH. Position paper on trans fatty acids. ASCN/AIN Task Force on Trans Fatty Acids. American Society for Clinical Nutrition and American Institute of Nutrition. Am J Clin Nutr 1996; 63: 663-670.
10. Ascherio A, Willett WC. Health effects of trans fatty acids. Am J Clin Nutr 1997; 66: 1006S-1010S. (Pubitemid 27418740)
11. Nelson GJ. Dietary fat, trans fatty acids, and risk of coronary heart disease. Nutr Rev 1998; 56: 250-252. (Pubitemid 28419774)
12. Stender S, Dyerberg J. Influence of trans fatty acids on health. Ann Nutr Metab 2004; 48: 61-66. (Pubitemid 38490244)
13. Anagnostopoulos D, Chatgilialoglu C, Ferreri C, Samadi A, Siafaka-Kapadai A. Synthesis of all-trans arachidonic acid and its effect on rabbit platelet aggregation. Bioorg Med Chem Lett 2005; 15: 2766-2770. (Pubitemid 40732216)
14. Ferreri C, Faraone Mennella MR, Formisano C, Landi L, Chatgilialoglu C. Arachidonate geometrical isomers generated by thiyl radicals: the relationship with trans lipids detected in biological samples. Free Radic Biol Med 2002; 33: 1516-1526. (Pubitemid 35351595)
15. Sakuma S, Fujimoto Y, Sakamoto Y, et al. Peroxynitrite induces the conversion of xanthine dehydrogenase to oxidase in rabbit liver. Biochem Biophys Res Commun 1997; 230: 476-479. (Pubitemid 27212024)
16. Sakuma S, Gotoh K, Sadatoku N, Fujita T, Fujimoto Y. Effects of antirheumatic gold compounds on the conversion of xanthine dehydrogenase to oxidase in rabbit liver cytosol in vitro. Life Sci 2004; 75: 1211-1218. (Pubitemid 38829346)
17. Sakuma S, Fujita J, Nakanishi M, Wada SI, Fujimoto Y. Disulfide Smonoxides convert xanthine dehydrogenase into oxidase in rat liver cytosol more potently than their respective disulfides. Biol Pharm Bull 2008; 31: 1013-1016. (Pubitemid 351731987)
18. Fujimoto Y, Morinaga K, Abe M, Kitamura T, Sakuma S. Selenite induces oxidative DNA damage in primary rat hepatocyte cultures. Toxicol Lett 2009; 191: 341-346.
19. Vanden Hoek TL, Li C, Shao Z, Schumacker PT, Becker LB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol 1997; 29: 2571-2583. (Pubitemid 27404448)
20. Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 1998; 273: 11619-11624. (Pubitemid 28272061)
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
22. Nishino T, Nishino T. The conversion from the dehydrogenase type to the oxidase type of rat liver xanthine dehydrogenase by modification of cysteine residues with fluorodinitrobenzene. J Biol Chem 1997; 272: 29859-29864. (Pubitemid 27508084)
23. Nishino T, Okamoto K, Kawaguchi Y, et al. Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant. J Biol Chem 2005; 280: 24888-24894. (Pubitemid 40934580)
24. Linas SL, Whittenburg D, Repine JE. Role of xanthine oxidase in ischemia/reperfusion injury. Am J Physiol 1990; 258: F711-F716. (Pubitemid 20103140)
25. McKelvey TG, Höllwarth ME, Granger DN, Engerson TD, Landler U, Jones HP. Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am J Physiol 1988; 254: G753-G760.
26. Wilson MR, Foucaud L, Barlow PG, et al. Nanoparticle interactions with zinc and iron: implications for toxicology and inflammation. Toxicol Appl Pharmacol 2007; 225: 80-89. (Pubitemid 350019484)
27. Tipton IH, Cook MJ. Trace elements in human tissue: part II. Adult subjects from the United States. Health Phys 1963; 9: 103-145.
28. Müller L, Abel J, Ohnesorge FK. Absorption and distribution of cadmium (Cd), copper and zinc following oral subchronic low level administration to rats of different binding forms of cadmium (Cd-acetate, Cd-metallothionein, Cd-glutathione). Toxicology 1986; 39: 187-195. (Pubitemid 16104303)
29. Chevion M, Jiang Y, Har-El R, Berenshtein E, Uretzky G, Kitrossky N. Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc Natl Acad Sci USA 1993; 90: 1102-1106. (Pubitemid 23053959)
30. Balazy M, Chemtob S. Trans-arachidonic acids: new mediators of nitro-oxidative stress. Pharmacol Ther 2008; 119: 275-290.
31. Kooli A, Kermorvant-Duchemin E, Sennlaub F, et al. Trans-Arachidonic acids induce a heme oxygenase-dependent vasorelaxation of cerebral microvasculature. Free Rad Biol Med 2008; 44: 815-825.
32. Sargis RM, Subbaiah PV. Trans unsaturated fatty acids are less oxidizable than cis unsaturated fatty acids and protect endogenous lipids from oxidation in lipoproteins and lipid bilayers. Biochemistry 2003; 42: 11533-11543. (Pubitemid 37205748)
33. Zaima N, Sugawara T, Arai H, et al. Characterization of trans eicosapentaenoic acid isomers: oxidative stability and anti-inflammatory activity. J Oleo Sci 2005; 54: 505-512.
34. Ratnayake WM, Chardigny JM, Wolff RL, Bayard CC, Sébédio JL, Martine L. Essential fatty acids and their trans geometrical isomers in powdered and liquid infant formulas sold in Canada. J Pediatr Gastroenterol Nutr 1997; 25: 400-407. (Pubitemid 27419174)
35. Okamoto T, Matsuzaki H, Maruyama T, Niiya I, Sugano M. Trans-fatty acid content in hydrogenated oils and estimated intake. J Jpn Oil Chem Soc 1999; 48: 1411-1414.